Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection

Seminars in Arthritis and Rheumatism

Volumn 32, Issue 1, 2002, Pages 56-63

  Ramos Casals, Manuel ^a,b   García Carrasco, Mario ^a,b   Cervera, Ricard ^a,b   Filella, Xavier ^a,b   Trejo, Olga ^a,b   De La Red, Gloria ^a,b   Gil, Víctor ^a,b   Sánchez Tapias, José Ma ^a,b   Font, Josep ^a,b   Ingelmo, Miguel ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Cytokines; Hepatitis C virus; Sj gren syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; PARIETAL CELL ANTIBODY; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CRYOGLOBULINEMIA; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOLOGICAL PROCEDURES; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; TH1 CELL; TH2 CELL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; PATHOPHYSIOLOGY;

AUTOANTIBODIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; MALE; SJOGREN'S SYNDROME; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036672461     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2002.33724     Document Type: Article

References (59)

1. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations
3. T1 vs T2 cytokine responses in chronic HCV: Implications for mechanisms of liver injury
4. Clinical and pathogenetic aspects of Sjögren's syndrome
5. Salivary and oral components of Sjögren's syndrome
6. Possible viral implication in the pathogenesis of Sjogren's syndrome
7. Murine cytomegalovirus induces a Sjögren's syndrome-like disease in C57B1/6-1pr/1pr mice
8. Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome
9. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease
10. Sicca syndrome associated with hepatitis C virus infection
11. Hepatitis C virus infection in "primary" Sjögren's syndrome: Prevalence and clinical significance in a series of 90 patients
12. Immunochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus
13. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: Comparison of Sjögren's syndrome
14. Hepatitis C virus infection mimicking primary Sjögren's syndrome. Clinical and immunologic description of 35 cases
15. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases. Results of a prospective multicenter study
16. Low dose alpha interferon therapy can be effective in chronic hepatitis C. Results of a multicenter, randomized trial
17. In situ detection of Hepatitis C virus RNA in salivary glands
18. Is hepatitis C virus a sialotropic virus?
19. Cryoglobulinemia in primary Sjögren's syndrome: Prevalence and clinical characteristics in a series of 115 patients
20. Sjögren's syndrome and lymphoproliferative disease
21. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection
22. CD30 induction and cytokine profiles in hepatitis C virus core-specific blood T lymphocytes
23. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
24. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection
25. The hepatitis C virus (HCV) induces a long-term increase in interleukin-10 production by human CD4+ T cells (H9)
26. Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein
27. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C
28. Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: Role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate
29. C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2b
30. Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b
31. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha
32. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa
33. Increased serum soluble IL-2 receptor levels following interferon therapy in patients with chronic hepatitis C
34. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: Correlation with clinical and immunological features
35. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgI2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
36. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile
37. A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C
38. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C
39. Autoantibodies and response to interferon in patients with chronic viral hepatitis
40. Evidence against hepatitis viruses as important causes of severe auto-immune hepatitis in the United states
41. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis
42. Absence of LKM 1 antibody in hepatitis C viral infection in the United States
43. Antinuclear antibodies and antismooth antibodies in hepatitis C virus infection
44. Non-organ specific autoantibodies associated with chronic C virus hepatitis
45. Prévalence et signification des anticorps antiorganites non spécifiques du foie au cours des hepatitis chroniques virales C
46. Existe-t-il un lien entre la presence d'autoanticorps ou d'une cryoglobulinemie mixte et les caracteres cliniques et histologiques de l'hepatite virale chronique C?
47. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
48. Virus-induced autoimmunity in hepatitis C virus infections: A rare event
49. Prevalence et caracteristiques des anticorps anti-tissus au cours des hepatites chroniques dues au virus de l'hepatite C
50. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
51. Immunological features and HLA associations in chronic viral hepatitis
52. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile
53. Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection
54. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients
55. Extrahepatic symptoms as presenting manifestations of hepatitis C virus infection
56. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients
57. Sjögren's syndrome and hepatitis C virus
58. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection
59. Prevalence and characteristics of Sjögren's syndrome or sicca syndrome in chronic hepatitis C virus infection: A prospective study